Advancing Vision. Designed for Every Eye. Helping shape the future of vision care with solutions that support people through every stage of life.
Dedication. Expertise. Leadership.
At CooperVision, we’re committed to advancing vision*1 through solutions designed for every eye and every stage of life.2,3 By combining innovation, expertise, and a deep understanding of people’s evolving vision needs, we’re helping more people around the world enjoy clear vision,†3-8 and comfortable lens wear3,9,10 today while creating possibilities for tomorrow.
Manufacturing the widest range of soft contact lens prescription options‡11
Selling in over 130 countries§1
Making billions of contact lenses annually1
From our groundbreaking introduction of contact lenses proven to slow the progression of myopia in age-appropriate children◊¶6±; to our DigitalBoost® Technology, developed to address the needs of contact lens wearers who lead digital lifestyles; to our creation of the world’s first full family of 1-day silicone hydrogel contact lenses, CooperVision is advancing the range of what contact lenses can do—and bringing ocular advantages to contact lens wearers.
Other important information:
*Combination of 2022 market research based on global volume data and internal estimates.
†VA (LogMAR) > 6/6 (20/20) at all visits from dispensing to 6-year visit.
‡Based on Rx option combinations (sphere, cylinder, axis and add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in silicone hydrogel and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic and photochromatic contact lenses not included. Multiple base curve variants not included.
§CooperVision® soft and specialty contact lenses and spectacle lenses.
◊Compared to a single vision 1 day lens over a 3-year period.
¶Product not available in all markets.
± Indications and Important Safety Information.
Rx only. Results may vary. ATTENTION: Reference the Package Insert or visit coopervision.ca/safety-mydaymisight for a complete listing of Indications and Important Safety Information. This product may not be right for you, talk to your Eye Care Professional. INDICATIONS: The MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00D to +2.00 diopters. The lenses may be worn by persons who exhibit astigmatism of -2.00 diopters or less that does not interfere with visual acuity. MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8- 16 hours) per day, 6.4 days (5-7) per week in a clinical study of MiSight 1 day (omafilcon A) containing identical dual focus optics to that of MyDay MiSight 1 day (stenfilcon A). Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MyDay MiSight 1 day (stenfilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal. WARNINGS: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulties with certain visually-demanding tasks. PRECAUTIONS: Daily wear single use only. Patients should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities. ADVERSE EVENTS: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.
References:
1. CVI data on file, 2023.
2. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years.
3. CVI data on file, 2026.
4. CVI data on file, 2024.
5. CVI data on file, 2020. Prospective, double-masked, bilateral, one-week dispensing study with MyDay® multifocal; n=102 habitual MFCL wearers.
6. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
7. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
8. CVI data on file, 2018. clariti 1 day satisfaction survey, n=1718. CVI data on file, 2018. 1-week bilateral DW study with c1d toric, n=39. CVI data on file, 2019. Woods J et al. Visual performance with DD SiH CN progressive design MFCL.
9. CVI data on file, 2018.Observational satisfaction survey in France, n=1718.
10. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.
11. CVI data on file, 2026. Industry reports and internal estimates based on Tyler's Quarterly, 06/2025.
12. CVI data on file, 2020.
SA20282